Chemoinformaics analysis of CINNAMYL 2-METHYLCROTONATE
Molecular Weight | 216.28 | nRot | 4 |
Heavy Atom Molecular Weight | 200.152 | nRig | 9 |
Exact Molecular Weight | 216.115 | nRing | 1 |
Solubility: LogS | -3.021 | nHRing | 0 |
Solubility: LogP | 3.372 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 35.6527 |
nHD | 0 | BPOL | 18.6553 |
QED | 0.57 |
Synth | 2.262 |
Natural Product Likeliness | 1.328 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.897 |
Pgp-sub | 0.001 |
HIA | 0.003 |
CACO-2 | -4.438 |
MDCK | 0.0000275 |
BBB | 0.255 |
PPB | 0.953436 |
VDSS | 1.368 |
FU | 0.0358325 |
CYP1A2-inh | 0.989 |
CYP1A2-sub | 0.866 |
CYP2c19-inh | 0.957 |
CYP2c19-sub | 0.399 |
CYP2c9-inh | 0.836 |
CYP2c9-sub | 0.489 |
CYP2d6-inh | 0.618 |
CYP2d6-sub | 0.497 |
CYP3a4-inh | 0.456 |
CYP3a4-sub | 0.328 |
CL | 10.787 |
T12 | 0.824 |
hERG | 0.047 |
Ames | 0.076 |
ROA | 0.104 |
SkinSen | 0.968 |
Carcinogencity | 0.295 |
EI | 0.976 |
Respiratory | 0.68 |
NR-Aromatase | 0.037 |
Antiviral | No |
Prediction | 0.55679 |